On September 10,2025,a senior Oncology management team from Johnson & Johnson Innovation Medicine visited Hangzhou DAC Biotechnology Co., Ltd. Dr. R. Zhao, CEO of the DAC company and his teams warmly welcomed the J&J management delegation. The two sides engaged in in-depth and productive scientific discussions.